Literature DB >> 32762362

Rapid Implementation of a Diabetes Telemedicine Clinic During the Coronavirus Disease 2019 Outbreak: Our Protocol, Experience, and Satisfaction Reports in Saudi Arabia.

Mohammed E Al-Sofiani1,2,3, Ebtihal Y Alyusuf1, Sahar Alharthi4, Abdullah M Alguwaihes1, Reem Al-Khalifah5, Assim Alfadda1,3,6.   

Abstract

BACKGROUND: The importance of telemedicine in diabetes care became more evident during the coronavirus disease 2019 (COVID-19) pandemic as many people with diabetes, especially those in areas without well-established telemedicine, lost access to their health care providers (HCPs) during this pandemic. SUBJECTS AND METHODS: We describe a simplified protocol of a Diabetes Telemedicine Clinic that utilizes technological tools readily available to most people with diabetes and clinics around the world. We report the satisfaction of 145 patients and 14 HCPs who participated in the virtual clinic and 210 patients who attended the virtual educational sessions about "Diabetes and Ramadan."
RESULTS: The majority of patients agreed or strongly agreed that the use of telemedicine was essential in maintaining a good glucose control during the pandemic (97%) and they would use the clinic again in the future (86%). A similar high satisfaction was reported by patients who attended the "Diabetes and Ramadan" virtual educational session and 88% of them recommended continuing this activity as a virtual session every year. Majority of the HCPs (93%) thought the clinic protocol was simple and did not require a dedicated orientation session prior to implementing.
CONCLUSIONS: The simplicity of our Diabetes Telemedicine Clinic protocol and the high satisfaction reported by patients and HCPs make it a suitable model to be adopted by clinics, especially during pandemics or disasters in resource-limited settings. This clinic model can be quickly implemented and does not require technological tools other than those widely available to most people with diabetes, nowadays. We were able to successfully reduce the number of patients, HCPs, and staff physically present in the clinics during the COVID-19 pandemic without negatively impacting the patients' nor the HCPs' satisfaction with the visits.

Entities:  

Keywords:  COVID-19; Saudi Arabia; diabetes; telemedicine

Mesh:

Year:  2020        PMID: 32762362      PMCID: PMC7925440          DOI: 10.1177/1932296820947094

Source DB:  PubMed          Journal:  J Diabetes Sci Technol        ISSN: 1932-2968


  28 in total

Review 1.  Constructs of depression and distress in diabetes: time for an appraisal.

Authors:  Frank J Snoek; Marijke A Bremmer; Norbert Hermanns
Journal:  Lancet Diabetes Endocrinol       Date:  2015-05-17       Impact factor: 32.069

2.  Telemedicine and the COVID-19 Pandemic, Lessons for the Future.

Authors:  Rashid Bashshur; Charles R Doarn; Julio M Frenk; Joseph C Kvedar; James O Woolliscroft
Journal:  Telemed J E Health       Date:  2020-04-08       Impact factor: 3.536

3.  Telehealth.

Authors:  Reed V Tuckson; Margo Edmunds; Michael L Hodgkins
Journal:  N Engl J Med       Date:  2017-10-19       Impact factor: 91.245

Review 4.  A Systematic Review of Reviews Evaluating Technology-Enabled Diabetes Self-Management Education and Support.

Authors:  Deborah A Greenwood; Perry M Gee; Kathy J Fatkin; Malinda Peeples
Journal:  J Diabetes Sci Technol       Date:  2017-05-31

5.  The relationship between diabetes distress and clinical depression with glycemic control among patients with type 2 diabetes.

Authors:  Lawrence Fisher; Russell E Glasgow; Lisa A Strycker
Journal:  Diabetes Care       Date:  2010-02-11       Impact factor: 19.112

Review 6.  5. Facilitating Behavior Change and Well-being to Improve Health Outcomes: Standards of Medical Care in Diabetes-2020.

Authors: 
Journal:  Diabetes Care       Date:  2020-01       Impact factor: 19.112

7.  Our Response to COVID-19 as Endocrinologists and Diabetologists.

Authors:  Ursula B Kaiser; Raghavendra G Mirmira; Paul M Stewart
Journal:  J Clin Endocrinol Metab       Date:  2020-05-01       Impact factor: 5.958

Review 8.  Telemedicine for diabetes care in India during COVID19 pandemic and national lockdown period: Guidelines for physicians.

Authors:  Amerta Ghosh; Ritesh Gupta; Anoop Misra
Journal:  Diabetes Metab Syndr       Date:  2020-04-04

Review 9.  Clinical considerations for patients with diabetes in times of COVID-19 epidemic.

Authors:  Ritesh Gupta; Amerta Ghosh; Awadhesh Kumar Singh; Anoop Misra
Journal:  Diabetes Metab Syndr       Date:  2020-03-10

10.  Estimation of effects of nationwide lockdown for containing coronavirus infection on worsening of glycosylated haemoglobin and increase in diabetes-related complications: A simulation model using multivariate regression analysis.

Authors:  Samit Ghosal; Binayak Sinha; Milan Majumder; Anoop Misra
Journal:  Diabetes Metab Syndr       Date:  2020-04-10
View more
  20 in total

Review 1.  SARS-CoV-2 infection in multiple sclerosis patients: interaction with treatments, adjuvant therapies, and vaccines against COVID-19.

Authors:  Ana Muñoz-Jurado; Begoña M Escribano; Eduardo Agüera; Javier Caballero-Villarraso; Alberto Galván; Isaac Túnez
Journal:  J Neurol       Date:  2022-07-05       Impact factor: 6.682

2.  EVALUATION OF A TELEHEALTH APPLICATION (SEHHA) USED DURING THE COVID-19 PANDEMIC IN SAUDI ARABIA: PROVIDER EXPERIENCE AND SATISFACTION.

Authors:  Mohanad M Alsaleh; Valerie J M Watzlaf; Dilhari R DeAlmeida; Andi Saptono
Journal:  Perspect Health Inf Manag       Date:  2021-10-01

3.  The worldwide impact of telemedicine during COVID-19: current evidence and recommendations for the future.

Authors:  Stefano Omboni; Raj S Padwal; Tourkiah Alessa; Béla Benczúr; Beverly B Green; Ilona Hubbard; Kazuomi Kario; Nadia A Khan; Alexandra Konradi; Alexander G Logan; Yuan Lu; Maurice Mars; Richard J McManus; Sarah Melville; Claas L Neumann; Gianfranco Parati; Nicolas F Renna; Philippe Ryvlin; Hugo Saner; Aletta E Schutte; Jiguang Wang
Journal:  Connect Health       Date:  2022-01-04

4.  Access to Healthcare during COVID-19.

Authors:  Alicia Núñez; S D Sreeganga; Arkalgud Ramaprasad
Journal:  Int J Environ Res Public Health       Date:  2021-03-14       Impact factor: 3.390

5.  Measuring the Patients' Satisfaction About Telemedicine Used in Saudi Arabia During COVID-19 Pandemic.

Authors:  Asmaa Abdel Nasser; Razan Mohammed Alzahrani; Chaimaa Aziz Fellah; Dimah Muwafak Jreash; Norah Talea A Almuwallad; Dunya Salem A Bakulka; Rabab Abdel Ra'oof Abed
Journal:  Cureus       Date:  2021-02-16

6.  Telemedicine Practice in Saudi Arabia During the COVID-19 Pandemic.

Authors:  Feroze Kaliyadan; Mohammed A Al Ameer; Ali Al Ameer; Qasem Al Alwan
Journal:  Cureus       Date:  2020-12-09

7.  The Impact of COVID-19 Pandemic Lockdown on the Incidence of New-Onset Type 1 Diabetes and Ketoacidosis Among Saudi Children.

Authors:  Aqeel Alaqeel; Fahad Aljuraibah; Mohammed Alsuhaibani; Mohammed Huneif; Abdulhameed Alsaheel; Mohammad Al Dubayee; Abdulaziz Alsaedi; Ayman Bakkar; Ahmed Alnahari; Areej Taha; Khulood Alharbi; Yousef Alanazi; Samia Almadhi; Reem Al Khalifah
Journal:  Front Endocrinol (Lausanne)       Date:  2021-04-01       Impact factor: 5.555

8.  Current status of telehealth in Saudi Arabia during COVID-19.

Authors:  Saeed M Alghamdi; Jaber S Alqahtani; Abdulelah M Aldhahir
Journal:  J Family Community Med       Date:  2020-09-25

9.  COVID-19 Precautionary Measures and Type 1 Diabetes Patients in Saudi Arabia.

Authors:  Abdullah Alguwaihes; Mohammed E Al-Sofiani; Ebtihal Alyusuf; Aeshah Almutairi; Eman Ibrahim; Sarah S Albunyan; Saad Alzahrani; Rana Hasanto; Anwar A Jammah
Journal:  Prim Care Diabetes       Date:  2021-07-15       Impact factor: 2.459

10.  Perception of virtual clinics among Saudi adults with type 1 diabetes during the COVID-19 pandemic.

Authors:  Sultan F Magliah; Ahmad S Alsabban; Haneen A Turkistani; Bahaa A Abulaban; Abdulaziz H Alsharif; Sarah S Alsharif; Hawazen A Zarif
Journal:  Diabetes Metab Syndr       Date:  2021-06-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.